Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Santo et al
In patients with type 2 diabetes and rheumatoid arthritis, retrospective analyses suggest that GLP-1 receptor agonists may provide glycemic and weight benefits comparable to those seen in the general diabetes population, without apparent increases in rheumatoid arthritis flares or complications, though these observations are based on small samples
Serious adverse events occurred at similar rates between semaglutide and placebo groups
Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm
US$ 22.59
US$ 27.16
US$ 21.24
US$ 25.94
